Filing Details

Accession Number:
0001179110-14-016436
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-12 16:44:29
Reporting Period:
2014-11-10
Filing Date:
2014-11-12
Accepted Time:
2014-11-12 16:44:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1065087 Albany Molecular Research Inc AMRI Services-Commercial Physical & Biological Research (8731) 141742717
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1449207 R Steven Hagen 26 Corporate Circle
Albany NY 12203
Svp Pharmaceutical Dev & Mfg No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-10 7,500 $5.99 38,433 No 4 M Direct
Common Stock Disposition 2014-11-10 7,500 $17.03 30,933 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to Purchase Common Stock Acquisiton 2014-11-10 7,500 $5.99 7,500 $5.99
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
22,500 2023-01-31 No 4 M Direct
Footnotes
  1. 50% of grant is time based and 50% is performance based. Time based grant vests 25% per year on each of the first 4 anniversaries of the date of grant (January 31, 2013). Performance based grant vests 25% per year on each of the first 4 anniversaries of the grant date if (1) certain performance criteria related to the Company's operating profitability are reached and (2) the grantee is employed on such anniversary date; if the foregoing criteria are not met on any anniversary date, 25% of the shares of options under the performance award will immediately be forfeited. The 7,500 shares being exercised represent a portion of the vested grants.